Thorsen Lene, Kirkegaard Camilla, Loge Jon Håvard, Kiserud Cecilie E, Johansen Merethe Lia, Gjerset Gunhild M, Edvardsen Elisabeth, Hamre Hanne, Ikdahl Tone, Fosså Sophie D
National Advisory Unit on Late Effects After Cancer Treatment, Oslo University Hospital, Box 4950, Nydalen, 0424 OSLO, Oslo, Norway.
Clinical Manager, Medical Affairs, Coloplast A/S, Humlebæk, Denmark.
BMC Res Notes. 2017 Jun 15;10(1):214. doi: 10.1186/s13104-017-2531-y.
Given the risk of developing acute and long-term adverse effects in patients receiving cisplatin-based chemotherapy for testicular cancer (TC), risk-reducing interventions, such as physical activity (PA), may be relevant. Limited knowledge is available on the challenges met when conducting PA intervention trials in patients with TC during and shortly after chemotherapy. The aims of the present feasibility study are therefore to determine patient recruitment, compliance and adherence to a PA intervention.
Patients with metastatic TC referred to cisplatin-based chemotherapy were eligible. They followed an individual low-threshold PA intervention, including counseling from a personal coach during and 3 months after chemotherapy. Outcomes were recruitment rate, compliance rate and adherence to the intervention including preferences for type of PA and barriers for PA. During 8 months 12 of 18 eligible patients were invited, all consented, but three dropped out. Walking and low intensity activities were preferred and nausea and feeling unwell were the most often reported barriers towards PA.
In order to achieve adequate recruitment, compliance and complete data in future PA intervention trials, close cooperation with treating physicians, individual PA plans and availability of personalized coaching are required. Trial registration NCT01749774, November 2012, ClinicalTrials.gov.
鉴于接受顺铂化疗的睾丸癌(TC)患者有发生急性和长期不良反应的风险,降低风险的干预措施,如体育活动(PA),可能具有相关性。关于在化疗期间及化疗后不久对TC患者进行PA干预试验时所面临的挑战,目前了解有限。因此,本可行性研究的目的是确定患者招募情况、对PA干预的依从性和坚持性。
符合条件的是接受基于顺铂化疗的转移性TC患者。他们接受了个性化的低门槛PA干预,包括在化疗期间及化疗后3个月接受私人教练的咨询。结果指标为招募率、依从率以及对干预措施的坚持性,包括对PA类型的偏好和PA的障碍。在8个月期间,邀请了18名符合条件的患者中的12名,所有患者均表示同意,但有3名退出。患者更喜欢步行和低强度活动,恶心和身体不适是最常报告的PA障碍。
为了在未来的PA干预试验中实现足够的招募、依从性和完整的数据,需要与治疗医生密切合作、制定个性化的PA计划并提供个性化指导。试验注册号NCT01749774,2012年11月,ClinicalTrials.gov。